|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| C07K 16/30 | (2006.01) | ||
| C07K 16/44 | (2006.01) | ||
| C07K 16/46 | (2006.01) |
| (11) | Number of the document | 3515487 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17784089.9 |
| Date of filing the European patent application | 2017-09-22 | |
| (97) | Date of publication of the European application | 2019-07-31 |
| (45) | Date of publication and mention of the grant of the patent | 2023-07-19 |
| (46) | Date of publication of the claims translation | 2023-08-25 |
| (86) | Number | PCT/US2017/053113 |
| Date | 2017-09-22 |
| (87) | Number | WO 2018/067331 |
| Date | 2018-04-12 |
| (30) | Number | Date | Country code |
| 201662399249 P | 2016-09-23 | US | |
| 201762558711 P | 2017-09-14 | US |
| (72) |
HABER, Lauric , US
SMITH, Eric , US
KELLY, Marcus , US
KIRSHNER, Jessica R. , US
COETZEE, Sandra , US
CRAWFORD, Alison , US
NITTOLI, Thomas , US
LIU, Yashu , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Bispecifiniai antikūnai prieš MUC16-CD3 ir vaistų konjugatai prieš MUC16 |
| BI SPECIFIC ANTI-MUC16-CD3 ANTIBODIES AND ANTI-MUC16 DRUG CONJUGATES |
| Payment date | Validity (years) | Amount | |
| 2025-08-20 | 9 | 208.00 EUR |
| 2026-09-22 |